441 related articles for article (PubMed ID: 35053496)
1. The Role of N
Zhao Y; Peng H
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053496
[TBL] [Abstract][Full Text] [Related]
2. Functions of RNA N
Zheng X; Gong Y
Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
[TBL] [Abstract][Full Text] [Related]
3. N
Weng H; Huang H; Chen J
Adv Exp Med Biol; 2023; 1442():105-123. PubMed ID: 38228961
[TBL] [Abstract][Full Text] [Related]
4. The role of mRNA m
Li J; Yang X; Qi Z; Sang Y; Liu Y; Xu B; Liu W; Xu Z; Deng Y
Cell Biosci; 2019; 9():66. PubMed ID: 31452869
[TBL] [Abstract][Full Text] [Related]
5. RNA modifications in hematological malignancies.
Jin Z; MacPherson K; Liu Z; Vu LP
Int J Hematol; 2023 Jun; 117(6):807-820. PubMed ID: 36929506
[TBL] [Abstract][Full Text] [Related]
6. Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis.
Wallace L; Obeng EA
Front Mol Biosci; 2023; 10():1273046. PubMed ID: 38028538
[TBL] [Abstract][Full Text] [Related]
7. Methylation modifications in eukaryotic messenger RNA.
Liu J; Jia G
J Genet Genomics; 2014 Jan; 41(1):21-33. PubMed ID: 24480744
[TBL] [Abstract][Full Text] [Related]
8. RNA modifications in hematopoietic malignancies: a new research frontier.
Qing Y; Su R; Chen J
Blood; 2021 Aug; 138(8):637-648. PubMed ID: 34157073
[TBL] [Abstract][Full Text] [Related]
9. Insights into novel emerging epigenetic drugs in myeloid malignancies.
Chandhok NS; Prebet T
Ther Adv Hematol; 2019; 10():2040620719866081. PubMed ID: 31431820
[TBL] [Abstract][Full Text] [Related]
10. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
Markouli M; Strepkos D; Piperi C
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362442
[TBL] [Abstract][Full Text] [Related]
11. RNA methylation in vascular disease: a systematic review.
Shu Y; Guo Y; Zheng Y; He S; Shi Z
J Cardiothorac Surg; 2022 Dec; 17(1):323. PubMed ID: 36536469
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine in hematological malignancies: a concise review.
Wang WJ; Xu TT; Bao J
Curr Opin Hematol; 2023 Jan; 30(1):4-13. PubMed ID: 36165537
[TBL] [Abstract][Full Text] [Related]
13.
Li P; Wang Y; Sun Y; Jiang S; Li J
Front Cell Dev Biol; 2022; 10():1055808. PubMed ID: 36407103
[TBL] [Abstract][Full Text] [Related]
14. The DNA methylation landscape of hematological malignancies: an update.
Blecua P; Martinez-Verbo L; Esteller M
Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
Zhao A; Zhou H; Yang J; Li M; Niu T
Signal Transduct Target Ther; 2023 Feb; 8(1):71. PubMed ID: 36797244
[TBL] [Abstract][Full Text] [Related]
17. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
18. Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis.
Langstein J; Milsom MD; Lipka DB
Semin Cancer Biol; 2018 Aug; 51():89-100. PubMed ID: 28964938
[TBL] [Abstract][Full Text] [Related]
19. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of adipose tissue expansion and adipogenesis by N
Wu R; Wang X
Obes Rev; 2021 Feb; 22(2):e13124. PubMed ID: 32935469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
